Spire Healthcare Group (LON:SPI) Shares Up 14.1% - What's Next?

Key Points

• Spire Healthcare Group shares surged by 14.1%, reaching a last trading price of GBX 247, significantly up from a previous close of GBX 216.50.
• Analysts have an average Buy rating for Spire Healthcare, with price targets ranging from GBX 280 to GBX 303, following recent upgrades by brokerages.
• The company's recent quarterly earnings report indicated an earnings per share of GBX 4.10, with expectations to post about 15.66 earnings per share for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) traded up 14.1% during trading on Saturday . The company traded as high as GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33). 9,747,062 shares were traded during trading, an increase of 563% from the average session volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analyst Upgrades and Downgrades

Several equities analysts recently commented on SPI shares. Berenberg Bank reaffirmed a "buy" rating and set a GBX 280 target price on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. lowered their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Spire Healthcare Group presently has an average rating of "Buy" and an average target price of GBX 294.33.

Spire Healthcare Group Trading Up 14.1%

The stock has a fifty day simple moving average of GBX 218.75 and a 200 day simple moving average of GBX 203.41. The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The firm has a market cap of £993.86 million, a P/E ratio of 5,369.57, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, research analysts expect that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.

Spire Healthcare Group Company Profile

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.